Zdrowie i gospodarka · 28/07/2011

FDA Seeks Public Comment on Proposed Blood and Blood Components Regulations

The Food and Drug Administration (FDA) is requesting public input on proposed regulations for blood and blood components, including requirements for donor testing and notification, as part of its current good manufacturing practice (CGMP) regulations.